Income Statement
SOTERA HEALTH CO
SHC
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
1,163.62 | 1,100.44 | 1,049.29 | 1,003.69 | 931.48 |
|
Cost of Revenue
|
518.08 | 498.15 | 472.13 | 446.68 | 412.81 |
|
Gross Profit
|
645.53 | 602.30 | 577.16 | 557.00 | 518.67 |
|
Operating Expenses
|
252.76 | 508.61 | 300.47 | 308.65 | 261.94 |
|
Research & Development
|
- | - | - | - | - |
|
Selling, General & Administrative
|
252.76 | 242.63 | 236.67 | 245.71 | 198.16 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
392.77 | 93.69 | 276.69 | 248.35 | 256.73 |
|
Non-Operating Income
|
245.27 | -20.19 | 170.67 | 491.46 | 81.02 |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
155.72 | 164.69 | 116.07 | 78.49 | 74.19 |
|
Other Non-Op Income / Expense
|
8.55 | 5.31 | 7.37 | 6.44 | 15.20 |
|
Income Before Tax
|
147.51 | 113.87 | 106.03 | -243.11 | 175.72 |
|
Income Tax Expense
|
69.56 | 69.48 | 0.00 | 0.00 | 0.00 |
|
Non-Controlling Interest
|
- | - | 0.00 | 0.00 | 0.24 |
|
Net Income
|
77.95 | 44.40 | 106.03 | -243.11 | 175.72 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
392.77 | 93.69 | 276.69 | 248.35 | 256.73 |
|
Earnings Per Share (Basic)
|
0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
|
Diluted EPS
|
0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
|
Weighted Average Shares
|
283.96 | 282.78 | 281.01 | 280.10 | 279.23 |
|
Diluted Weighted Avg Shares
|
286.42 | 284.91 | 283.22 | 280.10 | 279.38 |
|
Comprehensive Income
|
176.36 | -71.17 | 65.35 | -256.66 | 127.16 |